XML 48 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash Flows from Operating Activities:    
Net Loss $ (3,578,602) $ (887,581)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Stock Compensation Expense 226,287 192,050
Amortization of Debt Issuance Costs 26,618 0
Discount on Debt 88,120 2,428
Accrued interest on Debt 51,234 5,740
Change in Fair Value of Warrant and Bifurcated Conversion Liabilities (19,057) 56,131
Depreciation 209,619 123,461
Amortization of Intangibles 128,784 128,784
Changes in Operating Assets and Liabilities, Net of Effects of Acquisition    
Accounts Receivable (226,116) (297,986)
Inventories (10,359) 36,840
Prepaid Expenses & Other Current Assets 56,793 1,465
Accounts payable (504,200) (75,829)
Accrued expenses (183,641) (184,714)
Deferred revenue and customer deposits 26,418 115,945
Net Cash Used in Operating Activities (3,708,102) (783,266)
Cash Flows from Investing Activities:    
Purchase of Manufacturing Equipment (110,690) (839,465)
Net cash used in Investing Activities (110,690) (839,465)
Cash Flows from Financing Activities:    
Issuance of Convertible Debt, Net of Issuance Costs 4,192,239 0
Issuance of Common Stock, Net of Issuance Costs 0 992,500
Borrowings on Note Payable, Net of Issuance Costs 1,727,714 603,596
Repayments on Note Payable (140,886) 0
Reduction of Payable to Shareholders 0 (2,017)
Net Cash Provided by Financing Activities 5,779,067 1,594,079
Net Increase (Decrease) in Cash and Cash Equivalents 1,960,275 (28,652)
Cash and Cash Equivalents, beginning of period 149,703 1,123,518
Cash and Cash Equivalents, end of period 2,109,978 1,094,866
Non-Cash Investing and Financing Activities    
Issuance of Warrants/Common Stock as Finders’ Fees 40,890 0
Non-cash Interest Expense $ 165,972 $ 0